Antineoplastic antimetabolite with immunosuppressant properties. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Tumor Cells, Cultured Cell Line T-Lymphocytes Cell Line, Tumor Jurkat Cells Allografts Cells, Cultured Kidney Lymphocytes HL-60 Cells Mitochondria B-Lymphocytes Liver

Organisms14

Streptomyces Mice, Inbred BALB C Mice, Inbred C57BL Rats, Inbred Lew Narcissus Aster Plant Rats, Wistar Olacaceae Rats, Sprague-Dawley Mice, Inbred DBA Rats, Inbred F344 Rabbits Mice, Nude Saccharomyces cerevisiae

Diseases13

Leukemia L1210 Neoplasms Leukemia P388 Hypersensitivity, Delayed Neoplasms, Experimental Sarcoma 180 Phlebitis Disease Models, Animal Carcinoma, Ehrlich Tumor Breast Neoplasms Lung Neoplasms Colonic Neoplasms Autoimmune Diseases

Chemicals and Drugs120

Antimetabolites Immunosuppressive Agents Tacrolimus Antimetabolites, Antineoplastic Antineoplastic Agents Cyclosporine Polyenes Propylene Glycols Thioguanine 6-Mercaptopurine Tacrolimus Binding Proteins Vidarabine Phosphate 6-Aminonicotinamide Sirolimus Tetrahydrouridine Fluorouracil Azathioprine Pantothenic Acid Methotrexate Norleucine Deoxycytidine Mitomycin Mycophenolic Acid Cytarabine Floxuridine Amino Acid Isomerases Immunophilins Calcineurin Thymidylate Synthase Phosphonoacetic Acid Cyclosporins Antibiotics, Antineoplastic Guanine Sphingosine Peptidylprolyl Isomerase Tacrolimus Binding Protein 1A Spiro Compounds Antineoplastic Agents, Phytogenic Cyclophilins Ribosomal Protein S6 Kinases Lactones Carrier Proteins Antineoplastic Agents, Alkylating Ribonucleosides Enzyme Inhibitors Calmodulin-Binding Proteins Doxorubicin Cyclophilin A TOR Serine-Threonine Kinases IMP Dehydrogenase Heat-Shock Proteins Interleukin-2 Phospholipid Ethers Ellipticines Gallium Bryostatins Thiadiazines Receptors, Lysosphingolipid Cyclophosphamide Cyclohexanes Guanidines Amaryllidaceae Alkaloids Prednisolone Phosphotransferases (Alcohol Group Acceptor)RNA, Messenger Cisplatin DNA-Binding Proteins Paclitaxel Ionomycin Bibenzyls Protein-Serine-Threonine Kinases Dexamethasone Antibodies, Monoclonal Sulindac Daunorubicin Phosphoprotein Phosphatases Depsipeptides Glucocorticoids Epothilones Antifungal Agents Cytochrome P-450 CYP3A Androstadienes Amsacrine Recombinant Proteins NFATC Transcription Factors DNA Vanadium Compounds Cytochrome P-450 Enzyme System Etoposide Adrenal Cortex Hormones Prodrugs Lysophospholipids Anti-Bacterial Agents Hazardous Substances Ancitabine Thiosemicarbazones Bleomycin Transcription Factors Protein Kinases NF-kappa B Macrolides 2-Propanol Tumor Necrosis Factor-alpha Aminoacridines Vincristine Carmustine Tetradecanoylphorbol Acetate Topoisomerase II Inhibitors Farnesyltranstransferase Drugs, Investigational Creatinine Prednisone Isocoumarins Nitrogen Mustard Compounds Receptors, Interleukin-2 Camptothecin Dioxoles Suramin Cytokines Calcium

Analytical, Diagnostic and Therapeutic Techniques and Equipment46

Surgical Sponges Trabeculectomy Kidney Transplantation Antineoplastic Combined Chemotherapy Protocols Liver Transplantation Drug Screening Assays, Antitumor Immunosuppression Heart Transplantation Organ Transplantation Drug Therapy, Combination Gloves, Protective Treatment Outcome Drug Monitoring Lymphocyte Culture Test, Mixed Drug Administration Schedule Transplantation, Homologous Transplantation Chromatography, High Pressure Liquid Lymphocyte Activation Skin Transplantation Flow Cytometry Magnetic Resonance Spectroscopy Retrospective Studies Transfection Protective Devices Xenograft Model Antitumor Assays Administration, Oral Equipment and Supplies, Hospital Protective Clothing Drug Evaluation, Preclinical Blotting, Western Drug Evaluation Neoplasms, Experimental Neoplasm Transplantation Disease Models, Animal Models, Molecular Inhibitory Concentration 50 Area Under Curve Drug Compounding Antineoplastic Protocols Tumor Stem Cell Assay Models, Biological Comet Assay Lymphocyte Count Risk Factors Follow-Up Studies

Phenomena and Processes39

Drug Synergism Cell Division Apoptosis Graft Rejection Cell Survival Dose-Response Relationship, Drug Graft Survival Time Factors Drug Interactions Molecular Structure Cell Proliferation Phosphorylation Signal Transduction Amino Acid Sequence Protein Binding Lymphocyte Activation Structure-Activity Relationship Kinetics Transplantation Immunology Base Sequence Transfection Dental Physiological Processes Gene Expression Drug Resistance, Neoplasm Enzyme Activation Cell Cycle Mutation DNA Damage Transcription, Genetic Binding Sites Inhibitory Concentration 50 Gene Expression Regulation Cell Differentiation Area Under Curve Biological Transport Antibody Formation Drug Resistance, Multiple Lymphocyte Count Drug Resistance

Disciplines and Occupations1

Oncology Nursing

Technology, Industry, Agriculture4

Gloves, Protective Laundering Protective Devices Protective Clothing

Information Science3

Molecular Sequence Data Amino Acid Sequence Base Sequence

Named Groups4

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital Nurses

Health Care17

Treatment Outcome Occupational Exposure Retrospective Studies Medical Secretaries Oncology Nursing Equipment Contamination Decontamination Nursing Staff, Hospital Environmental Monitoring Personnel, Hospital Area Under Curve Antineoplastic Protocols Pharmacies Oncology Service, Hospital Risk Factors Nurses Follow-Up Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care

Antimetabolites Immunosuppressive Agents Tacrolimus Antimetabolites, Antineoplastic Antineoplastic Agents Surgical Sponges Cyclosporine Polyenes Propylene Glycols Thioguanine 6-Mercaptopurine Tacrolimus Binding Proteins Vidarabine Phosphate 6-Aminonicotinamide Sirolimus Tetrahydrouridine Fluorouracil Trabeculectomy Azathioprine Pantothenic Acid Methotrexate Norleucine Deoxycytidine Mitomycin Mycophenolic Acid Cytarabine Floxuridine Streptomyces Leukemia L1210 Amino Acid Isomerases Immunophilins Calcineurin Thymidylate Synthase Phosphonoacetic Acid Tumor Cells, Cultured Cyclosporins Drug Synergism Neoplasms Antibiotics, Antineoplastic Guanine Sphingosine Cell Division Peptidylprolyl Isomerase Apoptosis Tacrolimus Binding Protein 1A Kidney Transplantation Graft Rejection Antineoplastic Combined Chemotherapy Protocols Cell Line Cell Survival Spiro Compounds Antineoplastic Agents, Phytogenic Dose-Response Relationship, Drug Graft Survival Cyclophilins Ribosomal Protein S6 Kinases Lactones T-Lymphocytes Carrier Proteins Liver Transplantation Time Factors Antineoplastic Agents, Alkylating Ribonucleosides Cell Line, Tumor Drug Screening Assays, Antitumor Enzyme Inhibitors Calmodulin-Binding Proteins Doxorubicin Immunosuppression Molecular Sequence Data Cyclophilin A Drug Interactions TOR Serine-Threonine Kinases IMP Dehydrogenase Heat-Shock Proteins Jurkat Cells Leukemia P388 Heart Transplantation Mice, Inbred BALB C Allografts Interleukin-2 Organ Transplantation Cells, Cultured Molecular Structure Phospholipid Ethers Cell Proliferation Ellipticines Mice, Inbred C57BL Gallium Bryostatins Thiadiazines Drug Therapy, Combination Gloves, Protective Treatment Outcome Rats, Inbred Lew Phosphorylation Signal Transduction Drug Monitoring Lymphocyte Culture Test, Mixed Receptors, Lysosphingolipid

No FAQ available that match "antineoplastic antimetabolite with immunosuppressant properties"